Delta-Fly Pharma 4598

Using its proprietary module technology, pharmaceutical company Delta-Fly conducts R&D into new anticancer agents. Module technology is a unique drug discovery method that takes the active ingredients (modules) of anticancer agents from existing drugs whose patents have expired or whose development was halted due to side effects and combines them to create new drugs with an improved balance of clinical efficacy and safety.